Elanco Ventures
Elanco Animal Health
◆ Investment Thesis
Support and advance innovation in animal health through strategic investments in therapeutic advancements and supportive technologies.
◆ About Elanco Animal Health
Elanco Ventures is Elanco Animal Health’s corporate venture capital platform focused on early-stage animal health innovation, with an announced $25 million multi-year commitment and a planned launch in late 2026.[1] It targets Pre-Seed, Seed, and Series A companies working on therapeutic advancements and enabling technologies for animal care.[1]
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Notable Investments
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does Elanco Ventures invest in?
Elanco Ventures invests in Drug Discovery, Biotech, Diagnostics, Medtech and Healthtech Infrastructure at the pre-seed, seed and series-a stages.
Which geographies does Elanco Ventures focus on?
Elanco Ventures focuses on United States, and is headquartered in United States.